The biliary HCO₃⁻ umbrella

experimental evidence revisited

Abstract

Purpose of review 

To critically review most recent experimental evidence for the protective action of biliary HCO₃⁻ secretion against bile acid-induced bile duct damage and development of fibrosing cholangiopathy in humans and experimental animals.

Recent findings 

Studies in human cholangiocytes in vitro indicate that a biliary HCO₃⁻ umbrella protects against bile acid-induced cholangiocyte damage and apoptosis in humans. The Cl⁻/HCO₃⁻ exchanger, AE2, and an intact biliary glycocalyx appear crucial for its stability. Related studies with experimental animal models in vivo have to be interpreted with caution as humans and mice differ not only with regard to bile salt pool, but also their expression patterns of transport proteins and signalling molecules.

Summary 

Adequate biliary HCO₃⁻ secretion may protect against bile salt-induced cholangiopathies. Future therapeutic strategies in biliary diseases will aim at stabilizing the biliary HCO₃⁻ umbrella.